Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitesh Kumar

Showing results (11-20 of 193) with videos related to

Pageof 20
Sort By:
Journal of Biomaterials Science. Polymer Edition|September 18, 2020
PEGYLATION: an important approach for novel drug delivery systemDeepa Yadav, Hitesh Kumar Dewangan
Current Pharmaceutical Design|January 28, 2025
Advancements in Managing Schizophrenia through Classical Approaches, Mechanisms, and Deep Brain StimulationLokesh Dhote, Hitesh Kumar Dewangan
Molecular Diversity|February 24, 2025
Pterostilbene as a potent ESR-1 in breast cancer therapy: insights from network pharmacology, molecular docking, dynamics simulations, ADMET, and in vitro analysisHarneet Marwah, Hitesh Kumar Dewangan
Cancer Control : Journal of the Moffitt Cancer Center|December 4, 2024
Phytochemicals in Cancer Chemoprevention: Preclinical and Clinical StudiesNitish Lekhak, Hitesh Kumar Bhattarai
Current Pharmaceutical Design|October 27, 2025
Emerging Approaches to Brain Cancer Treatment: A Review of Targeting ModalitiesNitish Garg, Hitesh Kumar Dewangan
Molecular Biology Reports|October 16, 2012
2C-Methyl- D- erythritol 2,4-cyclodiphosphate synthase from Stevia rebaudiana Bertoni is a functional geneHitesh Kumar, Kashmir Singh, Sanjay Kumar
Current Pharmaceutical Design|February 17, 2025
Cancer Drug Targeting: Molecular Mechanism, Approaches, and Regulatory FrameworkRushikesh Somnath Chandel, Hitesh Kumar Dewangan
Journal of Oncology|July 7, 2022
Singlet Oxygen, Photodynamic Therapy, and Mechanisms of Cancer Cell DeathPrabal Singh Maharjan, Hitesh Kumar Bhattarai
Therapeutic Delivery|February 15, 2024
Delivery of nano-emulgel carrier: optimization, evaluation and <i>in vivo</i> anti-inflammation estimations for osteoarthritisRajni, Kamal Shah, Hitesh Kumar Dewangan
Current Drug Targets|December 7, 2022
Emerging Trends and Future Challenges of Nanovaccine Delivery <i>via</i> Nasal RouteHitesh Kumar Dewangan, Akash Raghuvanshi, Kamal Shah
Pageof 20

Showing results (11-20 of 193) with videos related to

Sort By:
Pageof 20
Journal of Biomaterials Science. Polymer Edition|September 18, 2020
PEGYLATION: an important approach for novel drug delivery systemDeepa Yadav, Hitesh Kumar Dewangan
Current Pharmaceutical Design|January 28, 2025
Advancements in Managing Schizophrenia through Classical Approaches, Mechanisms, and Deep Brain StimulationLokesh Dhote, Hitesh Kumar Dewangan
Molecular Diversity|February 24, 2025
Pterostilbene as a potent ESR-1 in breast cancer therapy: insights from network pharmacology, molecular docking, dynamics simulations, ADMET, and in vitro analysisHarneet Marwah, Hitesh Kumar Dewangan
Cancer Control : Journal of the Moffitt Cancer Center|December 4, 2024
Phytochemicals in Cancer Chemoprevention: Preclinical and Clinical StudiesNitish Lekhak, Hitesh Kumar Bhattarai
Current Pharmaceutical Design|October 27, 2025
Emerging Approaches to Brain Cancer Treatment: A Review of Targeting ModalitiesNitish Garg, Hitesh Kumar Dewangan
Molecular Biology Reports|October 16, 2012
2C-Methyl- D- erythritol 2,4-cyclodiphosphate synthase from Stevia rebaudiana Bertoni is a functional geneHitesh Kumar, Kashmir Singh, Sanjay Kumar
Current Pharmaceutical Design|February 17, 2025
Cancer Drug Targeting: Molecular Mechanism, Approaches, and Regulatory FrameworkRushikesh Somnath Chandel, Hitesh Kumar Dewangan
Journal of Oncology|July 7, 2022
Singlet Oxygen, Photodynamic Therapy, and Mechanisms of Cancer Cell DeathPrabal Singh Maharjan, Hitesh Kumar Bhattarai
Therapeutic Delivery|February 15, 2024
Delivery of nano-emulgel carrier: optimization, evaluation and <i>in vivo</i> anti-inflammation estimations for osteoarthritisRajni, Kamal Shah, Hitesh Kumar Dewangan
Current Drug Targets|December 7, 2022
Emerging Trends and Future Challenges of Nanovaccine Delivery <i>via</i> Nasal RouteHitesh Kumar Dewangan, Akash Raghuvanshi, Kamal Shah
Pageof 20